Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors

Experimental Cell Research

Volumn 317, Issue 8, 2011, Pages 1119-1133

  Oikawa, Yuko ^a   Hansson, Johan ^a   Sasaki, Takako ^b   Rousselle, Patricia ^c   Domogatskaya, Anna ^a   Rodin, Sergey ^a   Tryggvason, Karl ^a   Patarroyo, Manuel ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Integrin; Laminin; Melanoma; Migration

Indexed keywords

INTEGRIN RECEPTOR; ISOPROTEIN; KALININ; LAMININ; LAMININ 10; LAMININ 111; LAMININ 211; LAMININ 411; LAMININ ALPHA5; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 6;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; WESTERN BLOTTING;

IVA;

EID: 79953100685     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.12.019     Document Type: Article

References (56)

1. Houghton A.N., Polsky D. Focus on melanoma. Cancer Cell 2002, 2:275-278.
2. Liotta L.A., Kohn E.C. The microenviroment of the tumour-host interface. Nature 2001, 411:375-379.
3. Patarroyo M., Tryggvason K., Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol. 2002, 12:197-207.
4. Miner J.H., Yurchenco P.D. Laminin functions in tissue morphogenesis. Annu. Rev. Cell Dev. Biol. 2004, 20:255-284.
5. Scheele S., Nyström A., Durbeej M., Talts J.F., Ekblom M., Ekblom P. Laminin isoforms in development and disease. J. Mol. Med. 2007, 85:825-836.
6. Lugassy C., Barnhill R.L. Angiotropic melanoma and extravascular migratory metastasis. Adv. Anat. Pathol. 2007, 14:195-201.
7. Natali P.G., Nicotra M.R., Bellocci M., Cavaliere R., Bigotti A. Distribution of laminin and collagen type IV in beningn and malignant lesions of melanocytic origin. Int. J. Cancer 1985, 35:461-467.
8. Fligiel S.E., Laybourn K.A., Peters B.P., Ruddon R.W., Hiserodt J.C., Varani J. Laminin production by murine melanoma cells: possible involvement in cell motility. Clin. Exp. Metastasis 1986, 4:259-272.
9. Seftor R.E.B., Seftor E.A., Koshikawa N., Meltzer P.S., Gardner L.M., Bilban M., Stetler-Stevenson W.G., Quaranta V., Hendrix M.J. Cooperative interactions of laminin 5 γ2 chain, matrix metalloproteinase-2, and membrane type-1-matrix metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res. 2001, 61:6322-6327.
10. Aumailley M., Bruckner-Tuderman L., Carter W.G., Deutzmann R., Edgar D., Ekblom P., Engel J., Engvall E., Hohenester E., Jones J.C., Kleinman H.K., Marinkovich M.P., Martin G.R., Mayer U., Meneguzzi G., Miner J.H., Miyazaki K., Patarroyo M., Paulsson M., Quaranta V., Sanes J.R., Sasaki T., Sekiguchi K., Sorokin L.M., Talts J.F., Tryggvason K., Uitto J., Virtanen I., von der Mark K., Wewer U.M., Yamada Y., Yurchenco P.D. A simplified laminin nomenclature. Matrix Biol. 2005, 24:326-332.
11. Sasaki T., Timpl R. Domain IVa of laminin α5 chain is cell-adhesive and binds β1 and αVβ3 integrins through Arg-Gly-Asp. FEBS Lett. 2001, 509:181-185.
12. Nishiuchi R., Takagi J., Hayashi M., Ido H., Yagi Y., Sanzen N., Tsuji T., Yamada M., Sekiguchi K. Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin-integrin interactions using recombinant α3β1, α6β1, α7β1 and α6β4 integrin. Matrix Biol. 2006, 25:189-197.
13. McCarthy J.B., Furcht L.T. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J. Cell Biol. 1984, 98:1474-1480.
14. Ramos D.M., Berston E.D., Kramer R.H. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. Cancer Res. 1990, 50:728-734.
15. Melchiori A., Mortarini R., Carlone S., Marchisio P.C., Anichini A., Noonan D.M., Albini A. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp. Cell Res. 1995, 219:233-242.
16. Hangan D., Morris V.L., Boeters L., von Ballestrem C., Uniyal S., Chan B.M. An epitope on VLA-6 (α6β1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver. Cancer Res. 1997, 57:3812-3817.
17. Terranova V.P., Williams J.E., Liotta L.A., Martin G.R. Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science 1984, 226:982-985.
18. Ruiz P., Dunon D., Sonnenberg A., Imhof B.A. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. Cell Adhes. Commun. 1993, 1:67-81.
19. Virtanen I., Gullberg D., Rissanen J., Kivilaakso E., Kiviluoto T., Laitinen L.A., Lehto V.P., Ekblom P. Laminin α1 chain shows a restricted distribution in epithelial basement membranes of fetal and adult tissues. Exp. Cell Res. 2000, 257:298-309.
20. Vainionpää N., Butzow R., Hukkanen M., Jackson D.G., Pihlajaniemi T., Sakai L.Y., Virtanen I. Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas. Cell Tissue Res. 2007, 328:317-328.
21. Gorfu G., Virtanen I., Hukkanen M., Lehto V.P., Rousselle P., Kenne E., Lindbom L., Kramer R., Tryggvason K., Patarroyo M. Laminin isoforms of lymph nodes and predominant role of α5-laminin(s) in adhesion and migration of blood lymphocytes. J. Leukoc. Biol. 2008, 84:701-712.
22. Tsuji T., Kawada Y., Kai-Murozono M., Komatsu S., Han S.A., Takeuchi K., Mizushima H., Miyazaki K., Irimura T. Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). Clin. Exp. Metastasis 2002, 19:127-134.
23. Geberhiwot T., Wondimu Z., Salo S., Pikkarainen T., Kortesmaa J., Tryggvason K., Virtanen I., Patarroyo M. Chain specificity assignment of monoclonal antibodies to human laminins by using recombinant laminin β1 and γ1 chains. Matrix Biol. 2000, 19:163-167.
24. Doi M., Thyboll J., Kortesmaa J., Jansson K., Iivanainen A., Parvardeh M., Timpl R., Hedin U., Swedenborg J., Tryggvason K. Recombinant human laminin-10 (α5β1γ1). Production, purification, and migration-promoting activity on vascular endothelial cells. J. Biol. Chem. 2002, 277:12741-12748.
25. Kortesmaa J., Doi M., Patarroyo M., Tryggvason K. Chondroitin sulphate modification in the α4 chain of human recombinant laminin-8 (α4β1γ1). Matrix Biol. 2002, 21:483-486.
26. Wondimu Z., Geberhiwot T., Ingerpuu I., Juronen E., Xie X., Lindbom L., Doi M., Kortesmaa J., Thyboll J., Tryggvason K., Fadeel B., Patarroyo M. An endothelial laminin isoform, laminin 8 (α4β1γ1), is secreted by blood neutrophils, promotes neutrophil migration and extravasation, and protects neutrophils from apoptosis. Blood 2004, 104:1859-1866.
27. Wondimu Z., Gorfu G., Kawataki T., Smirnov S., Yurchenco P., Tryggvason K., Patarroyo M. Characterization of commercial laminin preparations from human placenta in comparison to recombinant human laminins 2 (α2β1γ1), 8 (α4β1γ1) and 10 (α5β1γ1). Matrix Biol. 2006, 25:89-93.
28. Vizirianakis I.S., Yao C.C., Chen Y., Ziober B.L., Tsiftsoglou A.S., Kramer R.H. Transfection of MCF-7 carcinoma cells with human integrin alpha 7 cDNA promotes adhesion to laminin. Arch. Biochem. Biophys. 2001, 385:108-116.
29. Kikkawa Y., Sanzen N., Sekiguchi K. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. Laminin-10/11 mediates cell adhesion through integrin α3β1. J. Biol. Chem. 1998, 273:15854-15859.
30. Rousselle P., Lunstrum G.P., Keene D.R., Burgeson R.E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J. Cell Biol. 1991, 114:567-576.
31. Petäjäniemi N., Korhonen M., Kortesmaa J., Tryggvason K., Sekiguchi K., Fujiwara H., Sorokin L., Thornell L.E., Wondimu Z., Assefa D., Patarroyo M., Virtanen I. Localization of laminin α4-chain in developing and adult human tissues. J. Histochem. Cytochem. 2002, 50:1113-1130.
32. Rousselle P., Aumailley M. Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors. J. Cell Biol. 1994, 125:205-214.
33. Kawataki T., Yamane T., Naganuma H., Rousselle P., Anduren I., Tryggvason K., Patarroyo M. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness, evidence for a role of α5-laminin(s) and α3β1 integrin: Exp. Cell Res. 2007, 313:3819-3831.
34. Pyke C., Salo S., Ralfkiaer E., Romer J., Dano K., Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 1995, 55:4132-4139.
35. Scott G., Cassidy L., Tran H., Rao S.K., Marinkovich M.P. Melanocytes adhere to and synthesize laminin-5 in vitro. Exp. Dermatol. 1999, 8:212-221.
36. McClenic B.K., Mitra R.S., Riser B.L., Nickoloff B.J., Dixit V.M., Varani J. Production and utilization of extracellular matrix components by human melanocytes. Exp. Cell Res. 1989, 180:314-325.
37. Zhang K., Kramer R.H. Laminin 5 deposition promotes keratinocyte motility. Exp. Cell Res. 1996, 227:309-322.
38. Massi D., Franchi A., Paglierani M., Ketabchi S., Borgognoni L., Reali U.M., Santucci M. Vascular mimicry has no significance in pT3 and pT4 cutaneous melanoma. Hum. Pathol. 2004, 35:496-502.
39. Prieto V.G., Woodruff J.M. Expression of basement membrane antigens in spindle cell melanoma. J. Cutan. Biol. 1998, 25:297-300.
40. Stracke M.L., Kohn E.C., Aznavoorian S.A., Wilson L.L., Salomon D., Krutzsch H.C., Liotta L.A., Schiffmann E. Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem. Biophys. Res. Comm. 1988, 153:1076-1083.
41. Stracke M.L., Engel J.D., Wilson L.W., Rechler M.M., Liotta L.A., Schiffmann E. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J. Biol. Chem. 1989, 264:21544-21549.
42. Ido H., Ito S., Taniguchi Y., Hayashi M., Sato-Nishiuchi R., Sanxen N., Hayashi Y., Futaki S., Sekiguchi K. Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to absence of the glutamic acid residue conserved in the C-terminal regions of the gamma1 and gamma2 chains. J. Biol. Chem. 2008, 283:28149-28157.
43. Albelda S.M., Mette S.A., Elder D.E., Stewart R., Damjanovich L., Herlyn M., Buck C.A. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 1990, 50:6757-6764.
44. Bair E.L., Chen M.L., McDaniel K., Sekiguchi K., Cress A.E., Nagle R.B., Bowden G.T. Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration. Neoplasia 2005, 7:380-389.
45. Zambruno G., Marchisio P.C., Melchiori A., Bondanza S., Cancedda R., De Luca M. Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes. J. Cell Sci. 1993, 105:179-190.
46. Natali P.G., Nicotra M.R., Cavaliere R., Giannarelli D., Bigotti A. Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor. Int. J. Cancer 1991, 49:168-172.
47. Natali P.G., Nicotra M.R., Bartolazzi A., Cavaliere R., Bigotti A. Integrin expression in cutaneous malignant melanoma: association of the alpha3/beta 1 heterodimer with tumor progression. Int. J. Cancer 1993, 54:68-72.
48. Schadendorf D., Gawlik C., Haney U., Ostmeier H., Suter L., Czarnetzki B.M. Tumor progression and metastatic behavior in vivo correlates with integrin expression on melanocytic tumors. J. Pathol. 1993, 170:429-434.
49. Danen E.H.J., Ten Berg P.J.M., van Muijen G.N.P., Van't Hof-Grootenboer A.E., Bröcker E.B., Ruiter D.J. Emergence of α5β1 fibronectin- and αVβ3 vitronectin-receptor expression in melanocytic tumor progression. Histopathol. 1994, 24:249-256.
50. Marshall J.F., Rutherford D.C., Happerfield L., Hanby A., McCartney A.C., Newton-Bishop J., Hart I.R. Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas. Br. J. Cancer 1998, 77:522-529.
51. Tsuji T. Physiological and pathological roles of alpha3beta1 integrin. J. Membr. Biol. 2004, 200:115-132.
52. Ziober B.L., Chen Y.Q., Ramos D.M., Waleh N., Kramer R.H. Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ. 1999, 10:479-490.
53. Zhou Z., Doi M., Wang J., Cao R., Liu B., Chan K.M., Kortesmaa J., Sorokin L., Cao Y., Tryggvason K. Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice. Cancer Res. 2004, 64:4059-4063.
54. Mortarini R., Gismondi A., Maggioni A., Santoni A., Herlyn M., Anichini A. Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. Cancer Res. 1995, 55:4702-4710.
55. Coles E.G., Gammill L.S., Miner J.H., Bronner-Fraser M. Abnormalities in neural crest cell migration in laminin alpha 5 mutant mice. Dev. Biol. 2006, 289:218-228.
56. Chia J., Kusuma N., Andreson R., Parker B., Bidwell B., Zamurs L., Nice E., Pouliot N. Evidence for a role of tumor-derived laminin-511 in metastatic progression of breast cancer. Am. J. Pathol. 2007, 170:2135-2148.